Scott Burrows
Director of Finance/CFO at SPYRE THERAPEUTICS, INC.
Net worth: 5 M $ as of 31/03/2024
Profile
Scott L.
Burrows is currently the Chief Financial & Accounting Officer at Spyre Therapeutics, Inc. He previously worked as the Head-International Investor Relations at Shire International GmbH (Switzerland) from 2018 to 2019 and as the Chief Financial & Accounting Officer at Arcutis Biotherapeutics, Inc. from 2019 to 2023.
Burrows received his undergraduate degree and MBA from the University of California, Los Angeles.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
SPYRE THERAPEUTICS, INC
0.37% | 15/02/2024 | 134,953 ( 0.37% ) | 5 M $ | 31/03/2024 |
03/04/2023 | 25,740 ( 0.02% ) | 255 083 $ | 31/03/2024 |
Scott Burrows active positions
Companies | Position | Start |
---|---|---|
SPYRE THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2023 |
Former positions of Scott Burrows
Companies | Position | End |
---|---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 31/08/2023 |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Investor Relations Contact | 01/05/2019 |
Training of Scott Burrows
University of California, Los Angeles | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
SPYRE THERAPEUTICS, INC. | Health Technology |
ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Health Technology |
- Stock Market
- Insiders
- Scott Burrows